In December 2011, project leader Kaisa Haglund in Harald Stenmark´s group was awarded a prestigious career grant ("utvidet forskerstipend") from Helse Sør-Øst for the proposal "Mechanisms of cytokinesis in development and carcinogenesis". The grant amounts to NOK 2 million per year and runs from April 2012 to March 2016.
Cancer Mutations in FGFR2 Prevent a Negative Feedback Loop Mediated by the ERK1/2 Pathway
Cells, 8 (6)
Crosstalk between p38 and Erk 1/2 in Downregulation of FGF1-Induced Signaling
Int J Mol Sci, 20 (8)
Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT-tamoxifen hybrid therapy
NPJ Breast Cancer, 5, 13